Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Akros Pharma Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy Subject Cohorts:
Healthy male or female subjects
Body Mass Index (BMI) between 19.0 and 31.0 kg/m2 (inclusive)
Type 2 Diabetic Subject Cohorts:
Male or female Type 2 diabetic subjects diagnosed for at least 3 months
BMI between 25 and 40 kg/m2 (inclusive)
Have a glycosylated hemoglobin (HbA1c) of \>6.5% to ≤10.9% (inclusive) if treatment naïve with respect to hypoglycemic agents OR \>6.5% to ≤10.0% (inclusive) if treated with metformin
You may not be if
Healthy Subject Cohorts:
Known clinically relevant history or presence of significant respiratory, gastrointestinal, renal, hepatic, hematological, lymphatic, neurological, cardiovascular, psychiatric, musculoskeletal, genitourinary, immunological, metabolic, and dermatological or connective tissue disease
Subjects with a systolic blood pressure \>150 mmHg and/or diastolic blood pressure \>90 mmHg
Type 2 Diabetic Subject Cohorts:
Subjects with a known medical history or presence of type 1 diabetes mellitus
Subjects with known medical history of acute metabolic diabetic complications
Subjects with uncontrolled hypertension (systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>95 mmHg with documented ongoing treatment)
